Jing J Ma from 1929 Cumbre Dr, San Pedro, CA 90732, age 67

Name / Title

Company / Classification

Phones & Addresses

Jing Guang Ma
President

MAZH INC
Nonclassifiable Establishments

252 S Western Ave, Los Angeles, CA 90004

Jing Ma
President

America Sepiolite Ore Fiber Products, Inc
Import and Export Ore Fiber Machine

4812 Del Amo Blvd, Torrance, CA 90503
310 370-7218

Jing Ma
President

AMERICA SEPIOLITE ORE AND FIBER PRODUCTS, INC

1011 S Fremont Ave, Alhambra, CA 91803

Jing Ma
President

LIMA TRADING, INC

18760 E Amar Rd STE 229, Walnut, CA 91789

Lawyers & Attorneys

Jing Ma - Lawyer

view source

Specialties:

Commercial Transactions
Mergers and Acquisitions
Securities
Corporate Law
Arbitration
Litigation

ISLN:

918685122

Admitted:

2005

University:

Peking University, Beijing, China, B.A., 1996; Peking University, Beijing, China, B.A., 1996; Peking University, Beijing, China, M.A., 1999; Peking University, Beijing, China, M.A., 1999

Law School:

Boston University, J.D., 2004

Resumes

Jing Ma

view source

Industry:

Electrical/Electronic Manufacturing

Education:

Xidian University 2000 - 2009

Jing Ma

view source

Skills:

Jing

Jing Ma

view source

Jing Ma

view source

Jing Ma

view source

Location:

United States

Us Patents

Antibodies Specific For Cancer Associated Antigen Sm5-1 And Uses Thereof
view source
US Patent:

20050232926, Oct 20, 2005
Filed:

Dec 2, 2004
Appl. No.:

11/004659
Inventors:

Jing Ma - Laguna Niguel CA, US
Yanjun Guo - Shanghai, CN
International Classification:

A61K039/395
C07H021/04
C12N015/09
C12N005/06
C07K016/30
US Classification:

424155100, 435069100, 435320100, 530388800, 536023530, 435344000
Abstract:

The invention concerns antibodies which is specific for SM5-1 antigen expressed in melanoma, breast cancer and hepatocellular carcinoma, and polynucleotides encoding the antibodies. The invention further concerns use of such antibodies and/or polynucleotides in diagnosing and treating malignancies.

Preparation And Application Of Anti-Tumor Bifunctional Fusion Proteins
view source
US Patent:

20050232931, Oct 20, 2005
Filed:

Dec 2, 2004
Appl. No.:

11/004639
Inventors:

Jing Ma - Laguna Niguel CA, US
Yanjun Guo - Shanghai, CN
International Classification:

A61K039/00
C07K014/82
US Classification:

424185100, 530350000
Abstract:

Provided herein is a chimeric protein, which chimeric protein comprises a Flt3 ligand, or a biologically active fragment thereof, and a proteinaceous or peptidyl tumoricidal agent, or a targeting agent which binds to a receptor expressed on a tumor, and uses thereof, particularly in the treatment of malignancy. Other embodiments and uses are disclosed.